Further investigation for LILRB4 and its ligand on IMs may elucidate the pathophysiology of COPD and its emphysematous lesions and possibly lead to the discovery of therapeutic targets for COPD. This evidence concerns the gene LILRB4 and chronic obstructive pulmonary disease.